ChengDu Sheng Nuo Biotec
688117
Nanjing Railway New Technology
301016
Tibet Duo Rui Pharmaceutical
301075
THEC
833509
Chengdu New Tianfu Culture Tourism Development
000558
CN Stock MarketDetailed Quotes
600933 IKD Co., Ltd.
- 16.82
- -0.62-3.56%
Trading Mar 31 09:37 CST
16.57BMarket Cap17.63P/E (TTM)
17.00High16.76Low43.61KlotVolume16.90Open17.44Pre Close73.59MTurnover0.45%Turnover Ratio17.63P/E (Static)984.86MShares22.7052wk High2.04P/B16.44BFloat Cap11.5952wk Low19.18Limit Up977.37MShs Float25.90Historical High15.70Limit Down1.38%Amplitude5.63Historical Low0.29Dividend TTM16.87Avg Price19.33KlotAsk1.72%Div YieldTTM100Lot Size18.02KlotBid
IKD Co., Ltd. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.24%6.75B | 17.46%4.97B | 22.92%3.25B | 30.69%1.64B | 39.67%5.96B | 39.92%4.23B | 44.19%2.64B | 39.19%1.26B | 33.05%4.27B | 28.68%3.03B |
| Operating revenue | 13.24%6.75B | 17.46%4.97B | 22.92%3.25B | 30.69%1.64B | 39.67%5.96B | 39.92%4.23B | 44.19%2.64B | 39.19%1.26B | 33.05%4.27B | 28.68%3.03B |
| Other operating revenue | ---- | ---- | -27.79%25.07M | ---- | ---- | ---- | -26.70%34.72M | ---- | -18.63%103.62M | ---- |
| Total operating cost | 16.40%5.73B | 19.60%4.2B | 27.95%2.77B | 28.67%1.38B | 39.01%4.92B | 38.45%3.51B | 34.71%2.16B | 29.88%1.08B | 20.57%3.54B | 19.75%2.53B |
| Operating cost | 14.49%4.88B | 17.32%3.53B | 23.59%2.32B | 30.64%1.16B | 38.38%4.26B | 36.25%3.01B | 36.53%1.88B | 27.76%884.11M | 30.43%3.08B | 29.35%2.21B |
| Operating tax surcharges | -18.57%56.96M | -27.56%39.11M | -37.09%24.13M | -55.30%10.38M | 140.93%69.95M | 177.12%53.99M | 185.17%38.35M | 157.06%23.21M | 33.32%29.03M | 4.48%19.48M |
| Operating expense | 11.90%52.62M | 4.01%57.71M | 3.88%37.41M | 18.09%20.37M | -26.07%47.02M | 36.76%55.48M | 49.56%36.01M | 46.32%17.25M | 46.78%63.61M | 27.79%40.57M |
| Administration expense | 13.50%365.21M | 23.91%292.57M | 18.78%175.84M | 15.48%85.36M | 28.25%321.76M | 29.05%236.13M | 24.46%148.04M | 22.46%73.92M | 4.31%250.88M | -0.33%182.97M |
| Financial expense | 149.58%28.62M | 120.49%8.14M | 167.06%39.47M | 135.98%29.58M | 33.51%-57.71M | 33.96%-39.72M | -225.65%-58.86M | 54.68%12.53M | -200.62%-86.81M | -238.86%-60.15M |
| -Interest expense (Financial expense) | 15.20%123.53M | 13.46%92.82M | 20.29%61.42M | 32.23%31.02M | 95.18%107.24M | 291.04%81.81M | 291.67%51.06M | 320.38%23.46M | 732.51%54.94M | 297.30%20.92M |
| -Interest Income (Financial expense) | -19.92%-123.91M | -17.11%-91.58M | -22.78%-60.39M | -54.35%-33.85M | -80.82%-103.33M | -266.62%-78.2M | -261.98%-49.18M | -38.81%-21.93M | -138.48%-57.14M | -17.77%-21.33M |
| Research and development | 24.15%348.23M | 38.64%268.97M | 39.20%174.41M | 28.96%83.11M | 36.69%280.49M | 35.58%194M | 32.44%125.29M | 37.87%64.45M | 11.26%205.2M | 8.58%143.09M |
| Credit Impairment Loss | 12.53%-23.23M | 66.11%-6.88M | 45.56%-6.24M | -104.51%-131.18K | -10.31%-26.56M | -6.07%-20.29M | -81.44%-11.47M | 146.19%2.91M | -1,015.61%-24.08M | -1,200.94%-19.13M |
| Asset Impairment Loss | 72.68%-2.7M | 170.68%4.04M | 566.16%2.99M | 592.84%4.83M | -18.48%-9.89M | -282.92%-5.72M | 157.82%449.03K | -73.93%697.47K | -21.89%-8.35M | 47.37%-1.49M |
| Other net revenue | 143.20%78.5M | 599.15%81.17M | 1,027.79%40.52M | 15.09%21.81M | 73.31%32.28M | -53.84%-16.26M | -119.39%-4.37M | 46.42%18.95M | -74.54%18.62M | -115.27%-10.57M |
| Fair value change income | 102.57%208.37K | 151.92%14.38M | 143.25%6.33M | -6.12%10.54M | -123.98%-8.1M | 20.74%-27.7M | -291.64%-14.64M | 626.17%11.22M | 22.09%-3.62M | -1,800.52%-34.95M |
| Invest income | 139.25%24.22M | 297.76%15.48M | -77.97%858.46K | -155.43%-7.12M | -57.08%10.12M | -82.12%3.89M | -76.42%3.9M | -133.23%-2.79M | -65.00%23.58M | -60.71%21.76M |
| -Including: Investment income associates | 65.02%9.51M | 11,684.02%7.38M | 3,421.53%5.44M | 11,739.75%4.98M | 465.92%5.76M | -37.42%62.66K | -38.03%154.46K | -117.17%-42.74K | 92.10%1.02M | -94.86%100.13K |
| Asset deal income | 645.19%6.16M | 600.38%6.04M | 432.26%3.19M | 492.85%1.28M | -282.58%-1.13M | -269.37%-1.21M | -267.58%-961.12K | -62.38%215.75K | 5,662.96%618.76K | 3,320.96%712.22K |
| Other revenue | 8.86%73.85M | 38.36%48.1M | 81.99%33.39M | 85.45%12.41M | 122.65%67.84M | 54.31%34.77M | 12.90%18.35M | 10.46%6.69M | 56.88%30.47M | 74.81%22.53M |
| Operating profit | 2.56%1.09B | 21.03%859.61M | 9.69%521.08M | 40.06%280.32M | 43.69%1.06B | 47.38%710.25M | 90.43%475.06M | 127.99%200.14M | 117.70%741.08M | 58.00%481.92M |
| Add:Non operating Income | 293.20%4.39M | 55.28%6.03M | 42.59%4.66M | -71.12%1.03M | -81.38%1.12M | -41.89%3.88M | -27.47%3.27M | -66.25%3.55M | -37.76%6M | -19.33%6.68M |
| Less:Non operating expense | 320.25%5.13M | 179.84%3.15M | 35.00%1.27M | -9.26%418.15K | -75.36%1.22M | -64.10%1.13M | -26.80%941.35K | 37.42%460.83K | 314.59%4.95M | 317.08%3.14M |
| Total profit | 2.50%1.09B | 20.97%862.49M | 9.86%524.47M | 38.23%280.93M | 43.47%1.06B | 46.87%713M | 88.93%477.38M | 107.43%203.23M | 112.73%742.12M | 55.32%485.47M |
| Less:Income tax cost | -14.08%119.32M | -7.54%92.11M | -20.88%53.18M | 34.37%36.9M | 103.72%138.88M | 69.43%99.62M | 133.34%67.21M | 215.42%27.46M | 161.49%68.17M | 141.43%58.8M |
| Net profit | 4.98%971.98M | 25.60%770.38M | 14.90%471.3M | 38.83%244.03M | 37.37%925.84M | 43.76%613.38M | 83.21%410.17M | 96.90%175.77M | 108.79%673.95M | 48.05%426.67M |
| Net profit from continuing operation | 4.98%971.98M | 25.60%770.38M | 14.90%471.3M | 38.83%244.03M | 37.37%925.84M | 43.76%613.38M | 83.21%410.17M | 96.90%175.77M | 108.79%673.95M | 48.05%426.67M |
| Less:Minority Profit | 161.09%32.47M | 81.29%28.59M | 50.29%21.53M | 89.52%12.15M | -51.06%12.44M | -18.29%15.77M | 33.44%14.32M | 46.16%6.41M | 96.81%25.41M | 107.29%19.3M |
| Net profit of parent company owners | 2.86%939.51M | 24.13%741.79M | 13.62%449.77M | 36.92%231.88M | 40.84%913.4M | 46.70%597.61M | 85.72%395.85M | 99.52%169.36M | 109.29%648.54M | 46.07%407.37M |
| Earning per share | ||||||||||
| Basic earning per share | -4.85%0.98 | 16.42%0.78 | 6.67%0.48 | 31.58%0.25 | 39.19%1.03 | 42.55%0.67 | 80.00%0.45 | 90.00%0.19 | 105.56%0.74 | 46.88%0.47 |
| Diluted earning per share | 2.15%0.95 | 17.19%0.75 | 6.98%0.46 | 26.32%0.24 | 30.99%0.93 | 39.13%0.64 | 79.17%0.43 | 90.00%0.19 | 97.22%0.71 | 43.75%0.46 |
| Other composite income | -346.25%-99.29M | -376.31%-76.65M | -109.84%-3.98M | -77.27%2.96M | 115.27%40.32M | 12.77%27.74M | 261.86%40.44M | 5,244.59%13.01M | 485.15%18.73M | 4,355.12%24.6M |
| Other composite income of parent company owners | -346.52%-98.79M | -376.17%-76.62M | -109.49%-3.84M | -77.11%2.98M | 113.95%40.08M | 12.77%27.74M | 261.86%40.44M | 5,244.59%13.01M | 485.15%18.73M | 4,355.12%24.6M |
| Other composite income of minority owners | -301.85%-498.4K | ---37.27K | ---139.4K | ---21.34K | --246.92K | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -9.67%872.69M | 8.21%693.73M | 3.71%467.32M | 30.83%246.99M | 39.48%966.16M | 42.07%641.12M | 91.71%450.62M | 112.07%188.78M | 117.88%692.68M | 56.90%451.27M |
| Total composite income of parent company owners | -11.83%840.72M | 6.37%665.17M | 2.21%445.93M | 28.78%234.86M | 42.89%953.48M | 44.77%625.35M | 94.50%436.29M | 115.49%182.37M | 118.77%667.27M | 55.21%431.97M |
| Total composite income of minority owners | 152.08%31.97M | 81.05%28.56M | 49.32%21.39M | 89.18%12.13M | -50.09%12.68M | -18.29%15.77M | 33.44%14.32M | 46.16%6.41M | 96.81%25.41M | 107.29%19.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
